Cargando…
Using Glycated Albumin and Stimulated C-Peptide to Define Partial Remission in Type 1 Diabetes
OBJECTIVE: To propose a new definition of partial remission (PR) for patients with type 1 diabetes (T1D) of all-ages using insulin dose and glycated albumin (GA), and find the optimal cut-off values for stimulated C-peptide to diagnose PR in different age-groups. RESEARCH DESIGN AND METHODS: Patient...
Autores principales: | Shi, Mei, Ji, Xiaolin, Xie, Yuting, Zhong, Ting, Tang, Rong, Fan, Li, Li, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344919/ https://www.ncbi.nlm.nih.gov/pubmed/35928900 http://dx.doi.org/10.3389/fendo.2022.938059 |
Ejemplares similares
-
The Remission Phase in Type 1 Diabetes: Role of Hyperglycemia Rectification in Immune Modulation
por: Tang, Rong, et al.
Publicado: (2019) -
Evaluation of biological variation of glycated hemoglobin and glycated albumin in healthy Chinese subjects
por: Liang, Libo, et al.
Publicado: (2018) -
Serum Albumin at Partial Remission Predicts Outcomes in Membranous Nephropathy
por: Lee, Taewoo, et al.
Publicado: (2020) -
Effect of Prestroke Glycemic Variability Estimated Glycated Albumin on Stroke Severity and Infarct Volume in Diabetic Patients Presenting With Acute Ischemic Stroke
por: Lee, Sang-Hwa, et al.
Publicado: (2020) -
Partial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes
por: Nwosu, Benjamin Udoka, et al.
Publicado: (2021)